Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Syndromic disease · Lymphatic system disorder
Hemophagocytic syndrome
Hemophagocytic syndrome (HPS) is a rare immune disease and a potentially life-threatening disorder characterized by cytokine storm and overwhelming inflammation causing fever, hepatosplenomegaly, cytopenia, hypertriglyceridemia, hyperferritinemia, and hemophagocytosis in bone marrow, liver, spleen or lymph nodes. It can be either primary due to a genetic defect (primary hemophagocytic lymphohistiocytosis), or secondary to malignancies, to infections, most commonly with viruses such as Epstein-Barr virus or cytomegalovirus, human immunodeficiency virus, or to autoimmune disorders such as systemic lupus erythematosus or adult-onset Still disease (secondary hemophagocytic lymphohistiocytosis).
-
Secondary hemophagocytic lymphohistiocytosis 15 trials · 24 incl. sub-types Sub-types →
-
Hereditary hemophagocytic lymphohistiocytosis 8 trials · 16 incl. sub-types Sub-types →